Last updated on December 2017

Childhood Atropine for Myopia Progression (CHAMP)

Brief description of study

The CHAMP study is designed to evaluate how two different concentrations of an investigational drug called Atropine Sulfate solution compare to placebo drops in slowing down the progression of nearsightedness (myopia) in children.

Clinical Study Identifier: TX155198

Contact Investigators or Research Sites near you

Start Over

Krystle Kang

Clinical Vision Research Center, SUNY College of Optometry
New York, NY USA
  Connect »